JP2008525317A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008525317A5 JP2008525317A5 JP2007542970A JP2007542970A JP2008525317A5 JP 2008525317 A5 JP2008525317 A5 JP 2008525317A5 JP 2007542970 A JP2007542970 A JP 2007542970A JP 2007542970 A JP2007542970 A JP 2007542970A JP 2008525317 A5 JP2008525317 A5 JP 2008525317A5
- Authority
- JP
- Japan
- Prior art keywords
- pregnane
- diol
- 3beta
- beta
- 5beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62951104P | 2004-11-18 | 2004-11-18 | |
| US60/629,511 | 2004-11-18 | ||
| PCT/SE2005/001671 WO2006054938A1 (en) | 2004-11-18 | 2005-11-07 | Gaba-steroid antagonists and their use for the treatment of cns disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008525317A JP2008525317A (ja) | 2008-07-17 |
| JP2008525317A5 true JP2008525317A5 (enExample) | 2008-12-25 |
| JP4914368B2 JP4914368B2 (ja) | 2012-04-11 |
Family
ID=36407411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007542970A Expired - Fee Related JP4914368B2 (ja) | 2004-11-18 | 2005-11-07 | Ｇａｂａ−ステロイド拮抗剤およびｃｎｓ疾患の治療のためのその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8114860B2 (enExample) |
| EP (1) | EP1812009B1 (enExample) |
| JP (1) | JP4914368B2 (enExample) |
| CN (1) | CN101076340B (enExample) |
| AU (1) | AU2005307151B2 (enExample) |
| BR (1) | BRPI0518359A2 (enExample) |
| CA (1) | CA2585359C (enExample) |
| DK (1) | DK1812009T3 (enExample) |
| ES (1) | ES2423493T3 (enExample) |
| MX (1) | MX2007006032A (enExample) |
| WO (1) | WO2006054938A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1812009T3 (da) | 2004-11-18 | 2013-08-05 | Umecrine Ab | GABA-steroidantagonister og deres anvendelse til behandling af CNS-lidelser |
| EP2711372A1 (en) | 2006-11-21 | 2014-03-26 | Umecrine AB | The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders |
| CN101585862B (zh) * | 2008-05-20 | 2014-12-17 | 梅克芳股份公司 | 甾族化合物 |
| US20110086828A1 (en) * | 2009-10-07 | 2011-04-14 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Treatment of alcohol abuse and alcoholism using modulators of neurosteroid binding sites on gabaa receptors |
| JP5687287B2 (ja) | 2010-01-14 | 2015-03-18 | ウメクライン ムード エービー | 改善された保存性及び溶解特性を有する３−ベータ−ヒドロキシ−５−アルファ−プレグナン−２０−オンを含有する薬学的組成物 |
| BE1030177B1 (nl) | 2022-02-04 | 2024-01-15 | Rousselot Bv | Gebruik van collageen hydrolysaat bij de preventie en/of behandeling van selectieve honger |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4614499A (en) * | 1985-04-29 | 1986-09-30 | Universite Laval | Simulator for use as a neurosurgical aid in determining potential paths for the implantation of probes through the human body |
| CN1270718C (zh) | 1998-03-11 | 2006-08-23 | 托布乔恩·贝克斯托罗姆 | 表别孕烷醇酮在制备治疗甾族化合物诱导的疾病的药物中的应用 |
| FR2806303B1 (fr) | 2000-03-17 | 2002-09-27 | Inst Nat Sante Rech Med | Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments |
| US20030125311A1 (en) * | 2000-03-17 | 2003-07-03 | Etienne-Emile Baulieu | Compounds capable of binding with the cytoskeleton |
| SE0104423D0 (sv) * | 2001-12-27 | 2001-12-27 | Umecrine Ab | Pregnane steroids and their use in the treatment of CNS disorders |
| DK1812009T3 (da) | 2004-11-18 | 2013-08-05 | Umecrine Ab | GABA-steroidantagonister og deres anvendelse til behandling af CNS-lidelser |
-
2005
- 2005-11-07 DK DK05801885.4T patent/DK1812009T3/da active
- 2005-11-07 AU AU2005307151A patent/AU2005307151B2/en not_active Ceased
- 2005-11-07 ES ES05801885T patent/ES2423493T3/es not_active Expired - Lifetime
- 2005-11-07 WO PCT/SE2005/001671 patent/WO2006054938A1/en not_active Ceased
- 2005-11-07 CA CA2585359A patent/CA2585359C/en not_active Expired - Fee Related
- 2005-11-07 JP JP2007542970A patent/JP4914368B2/ja not_active Expired - Fee Related
- 2005-11-07 MX MX2007006032A patent/MX2007006032A/es active IP Right Grant
- 2005-11-07 EP EP05801885.4A patent/EP1812009B1/en not_active Expired - Lifetime
- 2005-11-07 US US11/791,160 patent/US8114860B2/en not_active Expired - Fee Related
- 2005-11-07 BR BRPI0518359-6A patent/BRPI0518359A2/pt not_active IP Right Cessation
- 2005-11-07 CN CN2005800394888A patent/CN101076340B/zh not_active Expired - Fee Related
-
2012
- 2012-02-13 US US13/372,389 patent/US8372824B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014506321A5 (enExample) | ||
| JP2014515763A5 (enExample) | ||
| WO2008050329A3 (en) | Novel sirnas and methods of use thereof | |
| EP2331095A4 (en) | CYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE THEREOF | |
| JP2006522830A5 (enExample) | ||
| JP2009541348A5 (enExample) | ||
| JP2006527193A5 (enExample) | ||
| HK1199726A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| MA30290B1 (fr) | Therapie antitumorale a l'aide d'un anticorps contre le facteur de croissance endotheliale vasculaire et d'un anticorps contre le recepteur du facteur de croissance epitheliale humain de type 2 | |
| JP2014533279A5 (enExample) | ||
| HK1198619A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| JP2014510064A5 (enExample) | ||
| ATE421325T1 (de) | Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen | |
| JP2015505564A5 (enExample) | ||
| JP2010500370A5 (enExample) | ||
| JP2013231087A5 (enExample) | ||
| WO2009138186A3 (de) | SEQUENTIELLE VERARBEITUNG VON 20,20,21,21-PENTAFLUOR-17-HYDROXY-11β-[4-(HYDROXYACETYL) PHENYL] -19-NOR-17α-PREGNA-4,9-DIEN-3-ON UND EINEM ODER MEHREREN GESTAGENEN ZUR BEHANDLUNG GYNÄKOLOGISCHER ERKRANKUNGEN | |
| WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
| JP2005519893A5 (enExample) | ||
| CN115697386A (zh) | 一种治疗帕金森病的方法和药物 | |
| Chung et al. | Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation | |
| JP2019529569A5 (enExample) | ||
| AR061477A1 (es) | Metodos para utilizar un derivado de tiazol | |
| JP2015515974A5 (enExample) | ||
| JP2007518817A5 (enExample) |